Chatbot Avatar
Amplity Logo

Amplity Medical →

Outsourcing global clinical

& medical engagement for accelerated drug approval

& acceptance

Amplity Sales →

Flexible, scalable sales teams for rapid product launch

& lifecycle management

Amplity Intel →

Real-time patient-level insights powered by a
one-of-a-kind comprehensive
qualitative database + platform — AnswerY™

Amplity Comms →

Premium content & audience access to critical oncology care networks

Amplity Learn →

Continuous growth for teams and individuals led by pharma industry experts

Who We Are

Leadership

Who We Are

Leadership

Amplity Medical →
Amplity Sales →
Amplity Intel →
Amplity Comms →
Amplity Learn →

Expertise

Our Work

Our News

Careers

Contact Us
  • Amplity Intel
Neurology Rare Disease

AnswerY Delivers 19:1 ROI

Download PDF
Proprietary database + platform enable remote sales team to engage with an expanded list of HCPs who are treating patients earlier in their journey, specifically those presenting with multiple symptoms suggestive of the targeted rare disease. The result was faster treatment + 19:1 ROI for the client.
Download PDF
The Power of This Partnership

2

Weeks To Hit Annual Patient ID Goal

19:1

ROI On AnswerY Investment

30%

Savings With Pre-Launch Profiling

The Ask

CLIENT
U.S.
Mid-Sized BioPharma
Pinpoint Rare Disease Patients
Identify + prioritize HCPs to support a rare neurological disease medication launch.
Uncover New Potential Patients
Enhance patient journey mapping to speed up therapy initiation + improve outcomes.

The Approach

TOOLS
AnswerY
Remote Team
Patient Finding
Symptom Intersection Strategy
Pinpoint patients with specific symptom profiles by identifying the right HCPs.
Engage Right HCPs With Unique Dataset
Deploy remote sales team to use next-level intel to uncover patients who may have been overlooked in traditional claims data or ICD codes.

The Results

OUTCOME
Rare Patients Identified
Fast Tracked Care
Team Alignment
Quick Patient Identification
Uncovered more rare disease patients than company’s initial projection in 2 weeks by identifying HCPs not found in more commodified datasets, e.g. claims.
Deep ROI & 30% Savings With Smaller Field Team
Delivered 19:1 return on investment and reduced client’s field team footprint by 15 reps with prelaunch profiling.
Fast Tracked Treatment
Improved HCP’s ability to identify patients earlier in their diagnosis, leading to quicker treatment + better outcomes.
Data + Sales Synergy
Drove exceptional results by combining AnswerY with high-performing remote sales team.
Read Next

View All

View All

Medical
Young patients with ultra-rare diseases often do not achieve normal developmental milestones. 
Read Case Studyarrow
Nurse Teams, Rare Disease
•
Medical

23 of 100 Ultra-Rare Disease Patients Found

April 24, 2025
Research
Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) are rare, childhood-onset, developmental epileptic encephalopathies.
Explore Researcharrow
AI + NLP, Neurology, Rare Disease, RWE + HEOR
•
Research

Exploring The Clinical Burden Of Dravet Syndrome & Lennox-Gastaut Syndrome 

May 30, 2025
Research
Myasthenia gravis (MG) is a rare, chronic, autoantibody-mediated neuromuscular disorder.
Explore Researcharrow
AI + NLP, Rare Disease, RWE + HEOR
•
Research

Myasthenia Gravis Crisis: Treatment Challenges & Triggers 

May 21, 2025
Amplity.svg
About
Who We Are
Leadership
Services
Amplity Medical
Amplity Sales
Amplity Intel
Amplity Comms
Amplity Learn
Expertise
Our Work
Our News
Articles
Events
Multimedia
Press Release
Research
Careers
Contact
Amplity, Inc.
2080 Cabot Blvd W #100
Langhorne, PA 19047
© 2025 Amplity, Inc. All Rights Reserved.
Privacy & Cookie Statements
Terms of Use